Market Overview

Analysts Come Out Bullish On Radius Health, Shares Rally

Share:
Related RDUS
Benzinga's Volume Movers
The Top IPO Of 2014
Radius Health initiates equity offering (Seeking Alpha)

Early Wednesday morning, four analyst firms issued notes initiating bullish coverage on Radius Health (NASDAQ: RDUS).

Shares of Radius Health have shot up nearly six percent on the news. The firms respective ratings and price targets are listed below.

  • Canaccord Genuity - Buy, $21
  • Cowen & Company - Outperform, N/A
  • Cantor Fitzgerald - Buy, $20
  • Jefferies - Buy, $17

The average of these price targets is $19.33, which represents 53 percent upside to last check price of $12.62.

Latest Ratings for RDUS

DateFirmActionFromTo
Nov 2014Cantor FitzgeraldMaintainsBuy
Oct 2014Canaccord GenuityMaintainsBuy
Sep 2014Canaccord GenuityMaintainsBuy

View More Analyst Ratings for RDUS
View the Latest Analyst Ratings

Posted-In: Canaccord Genuity Cantor FitzgeraldAnalyst Color Price Target Initiation Hot Analyst Ratings Movers

 

Related Articles (RDUS)

Around the Web, We're Loving...

Get Benzinga's Newsletters